Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Einstein (São Paulo) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009 |
Resumo: | ABSTRACT Objective: To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy. Methods: A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013. Results: We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. On univariate analysis, hematological malignancies (p=0.005), the use of two or more chemotherapy (p=0.05) and high emetogenic risk regimes (p=0.012) were factors statistically associated with greater adherence to guidelines. Treatment based on paclitaxel was the only significant risk factor for non-adherence (p=0.02). By multivariate analysis, the chemotherapy of high emetogenic risk most correlated with adherence to guideline (p=0.05). Conclusion: We concluded that the adherence to guidelines is greater if the chemotherapy regime has high emetogenic risk. Educational efforts should focus more intensely on the management of chemotherapy regimens with low and moderate emetogenic potential. Perhaps the development of a computer generated reminder may improve the adherence to guidelines. |
id |
IIEPAE-1_c24ab63533149f9d447018968cf8e896 |
---|---|
oai_identifier_str |
oai:scielo:S1679-45082015000200009 |
network_acronym_str |
IIEPAE-1 |
network_name_str |
Einstein (São Paulo) |
repository_id_str |
|
spelling |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapyNausea/chemically inducedVomiting/chemically inducedClinical protocolsAdvance directive adherenceDrug therapy/adverse effectsAntiemeticsABSTRACT Objective: To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy. Methods: A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013. Results: We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. On univariate analysis, hematological malignancies (p=0.005), the use of two or more chemotherapy (p=0.05) and high emetogenic risk regimes (p=0.012) were factors statistically associated with greater adherence to guidelines. Treatment based on paclitaxel was the only significant risk factor for non-adherence (p=0.02). By multivariate analysis, the chemotherapy of high emetogenic risk most correlated with adherence to guideline (p=0.05). Conclusion: We concluded that the adherence to guidelines is greater if the chemotherapy regime has high emetogenic risk. Educational efforts should focus more intensely on the management of chemotherapy regimens with low and moderate emetogenic potential. Perhaps the development of a computer generated reminder may improve the adherence to guidelines.Instituto Israelita de Ensino e Pesquisa Albert Einstein2015-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009einstein (São Paulo) v.13 n.2 2015reponame:Einstein (São Paulo)instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)instacron:IIEPAE10.1590/S1679-45082015AO3097info:eu-repo/semantics/openAccessFrança,Monique SedlmaierUsón Junior,Pedro Luiz SerranoAntunes,Yuri Philippe Pimentel VieiraPrado,Bernard LobatoDonnarumma,Carlos del CistiaMutão,Taciana SousaRodrigues,Heloisa VeaseyGiglio,Auro deleng2015-12-03T00:00:00Zoai:scielo:S1679-45082015000200009Revistahttps://journal.einstein.br/pt-br/ONGhttps://old.scielo.br/oai/scielo-oai.php||revista@einstein.br2317-63851679-4508opendoar:2015-12-03T00:00Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)false |
dc.title.none.fl_str_mv |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy |
title |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy |
spellingShingle |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy França,Monique Sedlmaier Nausea/chemically induced Vomiting/chemically induced Clinical protocols Advance directive adherence Drug therapy/adverse effects Antiemetics |
title_short |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy |
title_full |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy |
title_fullStr |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy |
title_full_unstemmed |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy |
title_sort |
Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy |
author |
França,Monique Sedlmaier |
author_facet |
França,Monique Sedlmaier Usón Junior,Pedro Luiz Serrano Antunes,Yuri Philippe Pimentel Vieira Prado,Bernard Lobato Donnarumma,Carlos del Cistia Mutão,Taciana Sousa Rodrigues,Heloisa Veasey Giglio,Auro del |
author_role |
author |
author2 |
Usón Junior,Pedro Luiz Serrano Antunes,Yuri Philippe Pimentel Vieira Prado,Bernard Lobato Donnarumma,Carlos del Cistia Mutão,Taciana Sousa Rodrigues,Heloisa Veasey Giglio,Auro del |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
França,Monique Sedlmaier Usón Junior,Pedro Luiz Serrano Antunes,Yuri Philippe Pimentel Vieira Prado,Bernard Lobato Donnarumma,Carlos del Cistia Mutão,Taciana Sousa Rodrigues,Heloisa Veasey Giglio,Auro del |
dc.subject.por.fl_str_mv |
Nausea/chemically induced Vomiting/chemically induced Clinical protocols Advance directive adherence Drug therapy/adverse effects Antiemetics |
topic |
Nausea/chemically induced Vomiting/chemically induced Clinical protocols Advance directive adherence Drug therapy/adverse effects Antiemetics |
description |
ABSTRACT Objective: To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy. Methods: A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013. Results: We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. On univariate analysis, hematological malignancies (p=0.005), the use of two or more chemotherapy (p=0.05) and high emetogenic risk regimes (p=0.012) were factors statistically associated with greater adherence to guidelines. Treatment based on paclitaxel was the only significant risk factor for non-adherence (p=0.02). By multivariate analysis, the chemotherapy of high emetogenic risk most correlated with adherence to guideline (p=0.05). Conclusion: We concluded that the adherence to guidelines is greater if the chemotherapy regime has high emetogenic risk. Educational efforts should focus more intensely on the management of chemotherapy regimens with low and moderate emetogenic potential. Perhaps the development of a computer generated reminder may improve the adherence to guidelines. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1679-45082015AO3097 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Instituto Israelita de Ensino e Pesquisa Albert Einstein |
publisher.none.fl_str_mv |
Instituto Israelita de Ensino e Pesquisa Albert Einstein |
dc.source.none.fl_str_mv |
einstein (São Paulo) v.13 n.2 2015 reponame:Einstein (São Paulo) instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) instacron:IIEPAE |
instname_str |
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) |
instacron_str |
IIEPAE |
institution |
IIEPAE |
reponame_str |
Einstein (São Paulo) |
collection |
Einstein (São Paulo) |
repository.name.fl_str_mv |
Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) |
repository.mail.fl_str_mv |
||revista@einstein.br |
_version_ |
1752129907885867008 |